Relationship Between Serum Neopterin Level and Peripheral Arterial Plaque in Patients with Type 2 Diabetes

References

• Zheng Y , Ley SH , Hu FB . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol . 2018;14(2):88–98. doi:10.1038/nrendo.2017.151 29219149
   PubMed Web of Science ®Google Scholar
• Litwak L , Goh SY , Hussein Z , Malek R , Prusty V , Khamseh ME . Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study. Diabetol Metab Syndr . 2013;5(1):57. doi:10.1186/1758-5996-5-57 24228724
   PubMed Web of Science ®Google Scholar
• Marso SP , Hiatt WR . Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol . 2006;47(5):921–929. doi:10.1016/j.jacc.2005.09.065 16516072
   PubMed Web of Science ®Google Scholar
• Forbang NI , McDermott MM , Liao Y , et al. Associations of diabetes mellitus and other cardiovascular disease risk factors with decline in the ankle-brachial index. Vasc Med . 2014;19(6):465–472. doi:10.1177/1358863X14554033 25358555
   PubMed Web of Science ®Google Scholar
• Paneni F , Beckman JA , Creager MA , Cosentino F . Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J . 2013;34(31):2436–2443. doi:10.1093/eurheartj/eht149 23641007
   PubMed Web of Science ®Google Scholar
• Zheng L-Y , Xu X , Wan R-H , Xia S , Huang Q . Association between serum visfatin levels and atherosclerotic plaque in patients with type 2 diabetes. Diabetol Metab Syndr . 2019;11(1):60. doi:10.1186/s13098-019-0455-5 31367237
   PubMed Web of Science ®Google Scholar
• Steven G , Gregory BP , Angus L . Neopterin, Inflammation, and Oxidative Stress: what Could We Be Missing? Antioxidants . 2018;7(7):80. doi:10.3390/antiox7070080
   Web of Science ®Google Scholar
• Sugioka K , Naruko T , Matsumura Y , et al. Neopterin and atherosclerotic plaque instability in coronary and carotid arteries. J Atheroscler Thromb . 2010;17(11):1115–1121. doi:10.5551/jat.4606 20693747
   PubMed Web of Science ®Google Scholar
• Nazer B , Ray KK , Sloan S , et al. Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. Eur Heart J . 2011;32(11):1390–1397. doi:10.1093/eurheartj/ehr032 21345849
   PubMed Web of Science ®Google Scholar
• Ray KK , Morrow DA , Sabatine MS , et al. Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation . 2007;115(24):3071–3078. doi:10.1161/CIRCULATIONAHA.106.666511 17548728
   PubMed Web of Science ®Google Scholar
• Gieseg SP , Crone EM , Flavall EA , Amit Z . Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis. Br J Pharmacol . 2008;153(4):627–635. doi:10.1038/sj.bjp.0707408 17700723
   PubMed Web of Science ®Google Scholar
• Grossmann V , Schmitt VH , Zeller T , et al. Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes. Diabetes Care . 2015;38(7):1356–1364. doi:10.2337/dc14-3008 25877811
   PubMed Web of Science ®Google Scholar
• Unuvar S , Tanriverdi Z , Aslanhan H . Potential Prognostic Role of Immune System Activation Marker Neopterin in Patients with Type 2 Diabetes. J Med Biochem . 2018;37(4):465–469. doi:10.2478/jomb-2018-0004 30584406
   PubMed Web of Science ®Google Scholar
• Lee JE , Oh TJ , Moon JH , Park KS , Jang HC , Choi SH . Serum Neopterin Concentration and Impaired Glucose Metabolism: relationship With beta-Cell Function and Insulin Resistance. Front Endocrinol (Lausanne) . 2019;10:43. doi:10.3389/fendo.2019.00043 30873113
   PubMed Web of Science ®Google Scholar
• Cuta A , Drugan C , Roman G , Rusu A , Cătană CS . Evaluation of Chitotriosidase and Neopterin as Biomarkers of Microvascular Complications in Patients with Type 1 Diabetes Mellitus. Diagnostics . 2021;11(2):263. doi:10.3390/diagnostics11020263 33567717
   PubMed Web of Science ®Google Scholar
• Lyu Y , Jiang X , Dai W . The roles of a novel inflammatory neopterin in subjects with coronary atherosclerotic heart disease. Int Immunopharmacol . 2015;24(2):169–172. doi:10.1016/j.intimp.2014.11.013 25479720
   PubMed Web of Science ®Google Scholar
• Fredericks S . Neopterin Counters Vascular Inflammation and Atherosclerosis. J Am Heart Assoc . 2018.
   Web of Science ®Google Scholar
• Ma Y-C , Zuo L , Chen J-H . Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease. J Am Soc Nephrol . 2006;17(10):2937. doi:10.1681/ASN.2006040368 16988059
   PubMed Web of Science ®Google Scholar
• Auer J , Berent R , Lassnig E , Weber T , Eber B . Prognostic significance of immune activation after acute coronary syndromes. J Am Coll Cardiol . 2002;39(11):1878. doi:10.1016/S0735-1097(02)01875-2
   Web of Science ®Google Scholar
• Zouridakis E , Avanzas P , Arroyo-Espliguero R , Fredericks S , Kaski JC . Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation . 2004;110(13):1747–1753. doi:10.1161/01.CIR.0000142664.18739.92 15381646
   PubMed Web of Science ®Google Scholar
• Avanzas P , Arroyo-Espliguero R , Quiles J , Roy D , Kaski JC . Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J . 2005;26(5):457–463. doi:10.1093/eurheartj/ehi111 15684278
   PubMed Web of Science ®Google Scholar
• Vengen IT , Dale AC , Wiseth R , Midthjell K , Videm V . Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus: long-term follow-up of the HUNT 1 study. Atherosclerosis . 2009;207(1):239–244. doi:10.1016/j.atherosclerosis.2009.04.003 19409566
   PubMed Web of Science ®Google Scholar
• Herisson F , Heymann M , Chétiveaux M , et al. Carotid and femoral atherosclerotic plaques show different morphology. Atherosclerosis . 2011;216(2):348–354. doi:10.1016/j.atherosclerosis.2011.02.004 21367420
   PubMed Web of Science ®Google Scholar
• Zhou W , Chai H , Ding R , Lam H . Distribution of inflammatory mediators in carotid and femoral plaques. J Am Coll Surg . 2010;211(1):92–98. doi:10.1016/j.jamcollsurg.2010.02.054 20610254
   PubMed Web of Science ®Google Scholar
• VanderLaan P , Reardon C , Getz G . Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol . 2004;24(1):12–22. doi:10.1161/01.ATV.0000105054.43931.f0 14604830
   PubMed Web of Science ®Google Scholar
• Oettl K , Reibnegger G . Pteridine derivatives as modulators of oxidative stress. Curr Drug Metab . 2002;3(2):203–209. doi:10.2174/1389200024605127 12003351
   PubMed Web of Science ®Google Scholar
• Hoffmann G , Wirleitner B , Fuchs D . Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflammation Researc . 2003;52(8):313–321. doi:10.1007/s00011-003-1181-9
   Web of Science ®Google Scholar
• De Rosa S , Cirillo P , Pacileo M , et al. Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology. Curr Vasc Pharmacol . 2011;9(2):188–199. doi:10.2174/157016111794519372 21143176
   PubMed Web of Science ®Google Scholar
• Sucher R , Schroecksnadel K , Weiss G , Margreiter R , Fuchs D , Brandacher G . Neopterin, a prognostic marker in human malignancies. Cancer Lett . 2010;287(1):13–22. doi:10.1016/j.canlet.2009.05.008 19500901
   PubMed Web of Science ®Google Scholar
• Weiss M , Rodby R , Justice A , Hricik D . Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group. Kidney Int . 1998;54(1):193–202. doi:10.1046/j.1523-1755.1998.00982.x 9648079
   PubMed Web of Science ®Google Scholar
• Abdou A , Magour G , Mahmoud M . Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity. Br J Biomed Sci . 2009;66(3):143–147. doi:10.1080/09674845.2009.11730261 19839225
   PubMed Web of Science ®Google Scholar
• Aasbrenn M , Farup PG , Videm V . Changes in C-reactive protein, neopterin and lactoferrin differ after conservative and surgical weight loss in individuals with morbid obesity. Sci Rep . 2019;9(1):17695. doi:10.1038/s41598-019-54107-z 31776403
   PubMed Web of Science ®Google Scholar
• Bozdemir AE , Barutcuoglu B , Dereli D , Kabaroglu C , Habif S , Bayindir O . C-reactive protein and neopterin levels in healthy non-obese adults. Clin Chem Lab Med . 2006;44(3):317–321. doi:10.1515/CCLM.2006.055 16519605
   PubMed Web of Science ®Google Scholar
• Cox AJ , West NP , Cripps AW . Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol . 2015;3(3):207–215. doi:10.1016/S2213-8587(14)70134-2 25066177
   PubMed Web of Science ®Google Scholar